These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20017844)

  • 1. Risk of bacterial contamination from citrate catheter locks.
    Stranz M; Hadaway L
    Semin Dial; 2009; 22(6):704. PubMed ID: 20017844
    [No Abstract]   [Full Text] [Related]  

  • 2. Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.
    Moran JE; Ash SR;
    Semin Dial; 2008; 21(5):490-2. PubMed ID: 18764795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase: new indication. Thrombosed venous and dialysis catheters: when heparin fails. Urokinase clears about 75% of thrombosed venous catheters intended for long-term use with a dose-related increase in the bleeding risk.
    Prescrire Int; 2009 Jun; 18(101):118. PubMed ID: 19637430
    [No Abstract]   [Full Text] [Related]  

  • 4. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
    Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
    Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four percent trisodium citrate as an alternative anticoagulant for maintaining patency of central venous hemodialysis catheters: case report and discussion.
    Michaud D; Komant T; Pfefferle P
    Am J Crit Care; 2001 Sep; 10(5):351-4. PubMed ID: 11548568
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial.
    Bosma JW; Siegert CE; Peerbooms PG; Weijmer MC
    Nephrol Dial Transplant; 2010 Apr; 25(4):1213-7. PubMed ID: 19948873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra-low dose heparin locks perform well on non-tunnelled temporary haemodialysis catheters.
    Liang H; Liu XS; Wu YC; Zhang L; Lin QZ; Jie XN; Yang M; Su JX; Wang YS
    Nephrology (Carlton); 2015 Apr; 20(4):307-8. PubMed ID: 25810232
    [No Abstract]   [Full Text] [Related]  

  • 8. Temporary hemodialysis catheters as a long-term vascular access in chronic hemodialysis patients.
    Ponikvar R; Buturović-Ponikvar J
    Ther Apher Dial; 2005 Jun; 9(3):250-3. PubMed ID: 15967000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access.
    Bleyer AJ; Mason L; Russell G; Raad II; Sherertz RJ
    Infect Control Hosp Epidemiol; 2005 Jun; 26(6):520-4. PubMed ID: 16018426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of trisodium citrate and heparin as catheter-locking solution in hemodialysis patients.
    Bevilacqua JL; Gomes JG; Santos VF; Canziani ME
    J Bras Nefrol; 2011 Mar; 33(1):86-92. PubMed ID: 21541468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ultra-low dose and standard heparin locks on early tunnelled dialysis catheter outcomes in low-risk dialysis patients.
    Renaud CJ; Lim EK; Tho SJ; Yeoh LY
    Nephrology (Carlton); 2015 Feb; 20(2):85-90. PubMed ID: 25346031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ethanol/sodium citrate locking solution compared to heparin to prevent hemodialysis catheter-related infections: a randomized pilot study.
    Vercaigne LM; Allan DR; Armstrong SW; Zacharias JM; Miller LM
    J Vasc Access; 2016; 17(1):55-62. PubMed ID: 26660041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the flush characteristics of 2 peripheral vascular catheters.
    Chittick P; Sherertz RJ
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1311-3. PubMed ID: 21047185
    [No Abstract]   [Full Text] [Related]  

  • 14. [Is it possible to save an infected catheter?].
    Gaudry C; Kourilsky O
    Nephrologie; 1994; 15(2):171-2. PubMed ID: 8047208
    [No Abstract]   [Full Text] [Related]  

  • 15. Maintenance of peripheral and central intravenous infusion devices by 0.9% sodium chloride with or without heparin as a potential source of catheter microbial contamination.
    Calop J; Bosson JL; Croizé J; Laurent PE
    J Hosp Infect; 2000 Oct; 46(2):161-2. PubMed ID: 11049714
    [No Abstract]   [Full Text] [Related]  

  • 16. Central venous catheter-related infections: pathogenesis, predictors, and prevention.
    Hoppe B
    Heart Lung; 1995; 24(4):333-9; quiz 339-41. PubMed ID: 7591802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial contamination of haemodialysis catheter connections.
    Gorke A
    EDTNA ERCA J; 2005; 31(2):79-84. PubMed ID: 16180552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Central venous catheter: epidemiology, diagnosis, prevention and treatment of infectious complications].
    Quinet B
    Arch Pediatr; 2006 Jun; 13(6):718-20. PubMed ID: 16697607
    [No Abstract]   [Full Text] [Related]  

  • 19. Trisodium citrate 30% vs. heparin 5% as catheter lock in the interdialytic period in twin- or double-lumen dialysis catheters for intermittent haemodialysis.
    Stas KJ; Vanwalleghem J; De Moor B; Keuleers H
    Nephrol Dial Transplant; 2001 Jul; 16(7):1521-2. PubMed ID: 11427666
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial coating of central venous catheters: show me the data.
    Anaissie E
    Crit Care Med; 2007 Apr; 35(4):1197-9. PubMed ID: 17413788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.